Cliff Asness's NRC Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 122,206 shares of NRC Health (NRC) worth $2.64 M, representing 0.00% of the portfolio. First purchased in 2019-Q3, this long-term strategic position has been held for 28 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in NRC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 93,262 shares. Largest reduction occurred in Q2 2026, reducing 49,641 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's NRC Health (NRC) Holding Value Over Time
Track share changes against reported price movement
Quarterly NRC Health (NRC) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -49,641 | Reduce 28.89% | 122,206 | $21.57 |
| Q1 2026 | -44,929 | Reduce 20.73% | 171,847 | $16.98 |
| Q4 2025 | -49,049 | Reduce 18.45% | 216,776 | $18.77 |
| Q3 2025 | +64,429 | Add 31.99% | 265,825 | $12.78 |
| Q2 2025 | +93,262 | Add 86.25% | 201,396 | $16.80 |
| Q1 2025 | +67,882 | Add 168.64% | 108,134 | $12.80 |
| Q4 2024 | +17,217 | Add 74.74% | 40,252 | $17.64 |
| Q3 2024 | -5,901 | Reduce 20.39% | 23,035 | $22.86 |
| Q2 2024 | +4,601 | Add 18.91% | 28,936 | $22.95 |
| Q1 2024 | +12,097 | Add 98.85% | 24,335 | $39.61 |
| Q4 2023 | -17,493 | Reduce 58.84% | 12,238 | $39.56 |
| Q3 2023 | +3,950 | Add 15.32% | 29,731 | $44.37 |
| Q2 2023 | -11,421 | Reduce 30.70% | 25,781 | $43.51 |
| Q1 2023 | +6,086 | Add 19.56% | 37,202 | $43.51 |
| Q4 2022 | +3,223 | Add 11.55% | 31,116 | $37.30 |
| Q3 2022 | -11,255 | Reduce 28.75% | 27,893 | $39.79 |
| Q2 2022 | +5,054 | Add 14.82% | 39,148 | $38.29 |
| Q1 2022 | +21,894 | Add 179.46% | 34,094 | $39.66 |
| Q4 2021 | -1,206 | Reduce 9.00% | 12,200 | $41.56 |
| Q3 2021 | -13 | Reduce 0.10% | 13,406 | $42.15 |
| Q2 2021 | -1,087 | Reduce 7.49% | 13,419 | $45.91 |
| Q1 2021 | -17,844 | Reduce 55.16% | 14,506 | $46.81 |
| Q4 2020 | -20,618 | Reduce 38.93% | 32,350 | $42.75 |
| Q3 2020 | -29,798 | Reduce 36.00% | 52,968 | $49.22 |
| Q2 2020 | -5,412 | Reduce 6.14% | 82,766 | $58.21 |
| Q1 2020 | +53,277 | Add 152.65% | 88,178 | $45.48 |
| Q4 2019 | +8,927 | Add 34.37% | 34,901 | $65.93 |
| Q3 2019 | +25,974 | New Buy | 25,974 | $57.75 |
Cliff Asness's NRC Health Investment FAQs
Cliff Asness first purchased NRC Health (NRC) in Q3 2019, acquiring 25,974 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held NRC Health (NRC) for 28 quarters since Q3 2019.
Cliff Asness's largest addition to NRC Health (NRC) was in Q2 2025, adding 201,396 shares worth $3.38 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 122,206 shares of NRC Health (NRC), valued at approximately $2.64 M.
As of the Q2 2026 filing, NRC Health (NRC) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in NRC Health (NRC) was 265,825 shares, as reported at the end of Q3 2025.